These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20850201)

  • 1. [Cardiac safety of cinitapride].
    Mearín F; Plazas MJ; Mas M; Heras J
    Gastroenterol Hepatol; 2010 Oct; 33(8):614. PubMed ID: 20850201
    [No Abstract]   [Full Text] [Related]  

  • 2. The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
    Robert M; Salvà M; Segarra R; Pavesi M; Esbri R; Roberts D; Golor G
    Drug Metab Dispos; 2007 Jul; 35(7):1149-56. PubMed ID: 17437965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cisapride in children. The North American Society for Pediatric Gastroenterology and Nutrition.
    Shulman RJ; Boyle JT; Colletti RB; Friedman RA; Heyman MB; Kearns G; Kirschner BS; Levy J; Mitchell AA; Van Hare G
    J Pediatr Gastroenterol Nutr; 1999 May; 28(5):529-33. PubMed ID: 10328132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
    Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
    Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thorough QT/QTc Study Shows That a Novel 5-HT
    Hamatani T; Noda N; Takagaki T; Yodo Y; Kawai H; Kakuyama H; Kaji Y; Fujio Y
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):938-951. PubMed ID: 32087003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride (Prepulsid): interactions with grapefruit and drugs.
    Morawiecka I
    CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
    [No Abstract]   [Full Text] [Related]  

  • 7. The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.
    Meyers NL; Hickling RI
    J Int Med Res; 2007; 35(6):848-66. PubMed ID: 18034998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
    Serra J
    Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Vandenplas Y; Belli DC; Benatar A; Cadranel S; Cucchiara S; Dupont C; Gottrand F; Hassall E; Heymans HS; Kearns G; Kneepkens CM; Koletzko S; Milla P; Polanco I; Staiano AM
    J Pediatr Gastroenterol Nutr; 1999 May; 28(5):518-28. PubMed ID: 10328131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisapride and intestinal dysmotility: the final word?
    Craig JS
    Biol Neonate; 2005; 88(4):276-7. PubMed ID: 16113521
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced access to gastric motility drug will not sit well with many physicians or patients.
    Gordon D
    Gastroenterology; 2000 May; 118(5):818. PubMed ID: 10841640
    [No Abstract]   [Full Text] [Related]  

  • 12. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
    Pelov R; Tankova L; Krushkov I
    Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisapride and risk of cardiac complications].
    Cataldo F
    Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cisapride influence cardiac rhythm? Results of a United States multicenter, double-blind, placebo-controlled pediatric study.
    Levy J; Hayes C; Kern J; Harris J; Flores A; Hyams J; Murray R; Tolia V
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):458-63. PubMed ID: 11396814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long QT interval and malignant ventricular arrhythmia during treatment with cisapride. Report of a clinical case].
    Massari FM; Trevano FQ; Diehl L; Romano S
    Ital Heart J Suppl; 2000 Aug; 1(8):1055-8. PubMed ID: 10993015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New safety recommendations for use of cisapride (Propulsid).
    Harv Heart Lett; 2000 Apr; 10(8):7. PubMed ID: 10712753
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
    Tack J; Camilleri M; Chang L; Chey WD; Galligan JJ; Lacy BE; Müller-Lissner S; Quigley EM; Schuurkes J; De Maeyer JH; Stanghellini V
    Aliment Pharmacol Ther; 2012 Apr; 35(7):745-67. PubMed ID: 22356640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval effects of cisapride in the clinical setting.
    Wang SH; Lin CY; Huang TY; Wu WS; Chen CC; Tsai SH
    Int J Cardiol; 2001; 80(2-3):179-83. PubMed ID: 11578711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cisapride on the corrected QT interval and QT dispersion in premature infants.
    Cools F; Benatar A; Bougatef A; Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):178-81. PubMed ID: 11568520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.